Although alterations in IgA1 glycosylation certainly play an important role in the progression of kidney disease in IgAN, serum levels of galactose-deficient IgA1 are not necessarily elevated in a significant proportion of patients with IgAN [42, 43]. Here, IGHA1 is linked to kidney disorder.